{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:13:41Z","timestamp":1783509221233,"version":"3.55.0"},"reference-count":47,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:p>Prostate cancer is a leading cause of death. As a hormone-driven cancer, prostate cancer is often treated with drugs (luteinizing hormone receptor agonists; LHRHa) or surgical approaches (orchidectomy; ORX) with the goal of reducing androgens. These approaches cause side effects such as bone loss. It is unclear if the side effects of these approaches are due to loss of androgens or loss of estrogens, as these approaches reduce both. We seek to evaluate if LHRHa and ORX have equivalent effects on bone, if the bone loss can be ameliorated by estrogen supplementation, and if estrogen supplementation alone is sufficient to improve bone mass while reducing androgen production. Herein, we evaluated bone microarchitecture, mechanical properties, and the cellular mechanism of LHRHa with subsequent hormone add-back on bone. We find that LHRHa negatively affects bone microarchitecture but has more mild effects on bone than ORX. Estrogen supplementation \u2013 but not androgen supplementation \u2013 improves bone mass and strength in mice treated with LHRHa. Estrogen supplementation alone is also sufficient to improve bone mass and strength while also reducing androgen production. However, estrogen supplementation also increases osteoblast and osteoclast activity, which may promote prostate cancer metastasis in bone. Future studies should evaluate estrogen as a modulator of the metastatic niche.<\/jats:p>","DOI":"10.1530\/joe-25-0315","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:35:32Z","timestamp":1762864532000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":1,"title":["Estrogenic prevention of luteinizing hormone releasing hormone agonist-induced bone loss"],"prefix":"10.1530","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-912X","authenticated-orcid":true,"given":"K V","family":"Wells","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Goodson","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K E","family":"Lim","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Robling","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8599-2867","authenticated-orcid":true,"given":"D C","family":"Genetos","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2026070806152948300_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"2026070806152948300_bib2","first-page":"293","article-title":"Studies on Prostatic Cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"2026070806152948300_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies of prostatic cancer II. The effects of castration on advanced carcinoma of the prostate gland","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch Surg"},{"key":"2026070806152948300_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(21)00100-8","article-title":"Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised prostate adenocarcinoma transcutaneous hormone (PATCH) trial programme","volume":"397","author":"Langley","year":"2021","journal-title":"Lancet"},{"key":"2026070806152948300_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bju.13687","article-title":"Quality-of-life outcomes from the prostate adenocarcinoma: transcutaneous hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer","volume":"119","author":"Gilbert","year":"2017","journal-title":"BJU Int"},{"key":"2026070806152948300_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.eururo.2015.11.030","article-title":"A randomised comparison evaluating changes in bone mineral density in advanced prostate cancer: luteinising hormone-releasing hormone agonists versus transdermal oestradiol","volume":"69","author":"Langley","year":"2016","journal-title":"Eur Urol"},{"key":"2026070806152948300_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00345-009-0373-5","article-title":"Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats","volume":"27","author":"Stuermer","year":"2009","journal-title":"World J Urol"},{"key":"2026070806152948300_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"key":"2026070806152948300_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","article-title":"Osteoporosis after orchiectomy for prostate cancer","volume":"157","author":"Daniell","year":"1997","journal-title":"J Urol"},{"key":"2026070806152948300_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/jcem-68-2-461","article-title":"Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5\u03b1-reductase activity and androgen receptor content","volume":"68","author":"Forti","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806152948300_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2014.01.011","article-title":"Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation","volume":"141","author":"Handelsman","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070806152948300_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women\u2019s lives","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"2026070806152948300_bib13","first-page":"1765","article-title":"A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index","volume":"4","author":"Imbriaco","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2026070806152948300_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00223-016-0171-1","article-title":"Six weeks of daily abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in ovariectomized osteopenic rats","volume":"99","author":"Bahar","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"2026070806152948300_bib15","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.84.17.6267","article-title":"17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106","volume":"84","author":"Gray","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070806152948300_bib16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.85.7.2307","article-title":"Enhanced osteoblast proliferation and collagen gene expression by estradiol","volume":"85","author":"Ernst","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070806152948300_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/endo-125-2-825","article-title":"Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones","volume":"125","author":"Ernst","year":"1989","journal-title":"Endocrinology"},{"key":"2026070806152948300_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.3164526","article-title":"Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells","volume":"241","author":"Komm","year":"1988","journal-title":"Science"},{"key":"2026070806152948300_bib19","first-page":"88","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"New Ser"},{"key":"2026070806152948300_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.5650101013","article-title":"In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis","volume":"10","author":"Most","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bone.2005.10.003","article-title":"Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing","volume":"38","author":"Jung","year":"2006","journal-title":"Bone"},{"key":"2026070806152948300_bib22","first-page":"82","article-title":"Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood","volume":"110","author":"Jung","year":"2007","journal-title":"Am Soc Hematol"},{"key":"2026070806152948300_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1541-7786.MCR-14-0118","article-title":"Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow","volume":"13","author":"Jung","year":"2015","journal-title":"Mol Cancer Res"},{"key":"2026070806152948300_bib24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/jbmr.4313","article-title":"Osteoblasts generate testosterone from DHEA and activate androgen signaling in prostate cancer cells","volume":"36","author":"Moon","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mce.2015.11.013","article-title":"Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis","volume":"422","author":"Hagberg Thulin","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2026070806152948300_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ccell.2018.10.002","article-title":"The osteogenic niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability","volume":"34","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"2026070806152948300_bib27","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/en.2004-1211","article-title":"Bone turnover mediates preferential localization of prostate cancer in the skeleton","volume":"146","author":"Schneider","year":"2005","journal-title":"Endocrinology"},{"key":"2026070806152948300_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4161\/cbt.2.6.531","article-title":"In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice","volume":"2","author":"Kalikin","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"2026070806152948300_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1158\/1535-7163.MCT-18-1337","article-title":"GnRH antagonists have direct inhibitory effects on castration-resistant prostate cancer via intracrine androgen and AR-V7 expression","volume":"18","author":"Cucchiara","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2026070806152948300_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10724","article-title":"Degradation-resistant hypoxia inducible Factor-2\u03b1 in murine osteocytes promotes a high bone mass phenotype","volume":"7","author":"Mendoza","year":"2023","journal-title":"JBMR Plus"},{"key":"2026070806152948300_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bone.2016.09.001","article-title":"Sost, independent of the non-coding enhancer ECR5, is required for bone mechanoadaptation","volume":"92","author":"Robling","year":"2016","journal-title":"Bone"},{"key":"2026070806152948300_bib32","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"2026070806152948300_bib34","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.1207188109","article-title":"Targeted deletion of sost distal enhancer increases bone formation and bone mass","volume":"109","author":"Collette","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070806152948300_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI106877","article-title":"Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome","volume":"51","author":"Kelch","year":"1972","journal-title":"J Clin Investig"},{"key":"2026070806152948300_bib38","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/endo.132.3.8440194","article-title":"Germ cells of the mouse testis express P450 aromatase","volume":"132","author":"Nitta","year":"1993","journal-title":"Endocrinology"},{"key":"2026070806152948300_bib39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1359\/jbmr.090208","article-title":"Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects","volume":"24","author":"Sj\u00f6gren","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11095-006-9152-9","article-title":"Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats","volume":"24","author":"Kearbey","year":"2007","journal-title":"Pharm Res"},{"key":"2026070806152948300_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00365598609040556","article-title":"Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma: a preliminary report from a randomized multicenter study","volume":"20","author":"Lundgren","year":"1986","journal-title":"Scand J Urol Nephrol"},{"key":"2026070806152948300_bib42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/ERC-14-0199","article-title":"Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone","volume":"21","author":"Ottewell","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"2026070806152948300_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jbmr.3014","article-title":"The effects of aging and sex steroid deficiency on the Murine skeleton are independent and mechanistically distinct","volume":"32","author":"Ucer","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026070806152948300_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","article-title":"17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens","volume":"89","author":"Girasole","year":"1992","journal-title":"J Clin Investig"},{"key":"2026070806152948300_bib45","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI86062","article-title":"Sex steroid deficiency\u2013associated bone loss is microbiota dependent and prevented by probiotics","volume":"126","author":"Li","year":"2016","journal-title":"J Clin Investig"},{"key":"2026070806152948300_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S8756-3282(03)00199-6","article-title":"Bone development and age-related bone loss in male C57BL\/6J mice","volume":"33","author":"Ferguson","year":"2003","journal-title":"Bone"},{"key":"2026070806152948300_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/geronj\/29.2.134","article-title":"Enlarged seminal vesicles of senescent C57BL\/6J mice","volume":"29","author":"Finch","year":"1974","journal-title":"J Gerontol"}],"container-title":["Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/267\/2\/JOE-25-0315.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/267\/2\/JOE-25-0315.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0315\/507362\/joe-25-0315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0315\/507362\/joe-25-0315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:15:36Z","timestamp":1783505736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article\/267\/2\/e250315\/75969\/Estrogenic-prevention-of-luteinizing-hormone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1530\/joe-25-0315","relation":{},"ISSN":["1479-6805","0022-0795"],"issn-type":[{"value":"1479-6805","type":"electronic"},{"value":"0022-0795","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"e250315"}}